Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abiomed Inc (NQ: ABMD )

301.22 USD +5.59 (+1.89%)
Official Closing Price Updated: 7:55 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Abiomed Inc

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Abiomed Announces Appointment of Dr. Myron Rolle to Board of Directors
Abiomed announces the appointment of Myron Rolle, MD, to the Abiomed Board of Directors. 
From Business Wire News Releases
Abiomed to Present at Upcoming Investor Conferences
Abiomed to present at upcoming investor conferences. 
From Business Wire News Releases
Large Clinical Study Presented at STS 2021 Finds 79% Survival Rate with Impella 5.5 with SmartAssist
Abiomed (NASDAQ: ABMD) announces a large study of 356 patients treated with Impella 5.5 with SmartAssist at 16 U.S. and German centers found a 79% survival rate at explant. A majority of surviving... 
From Business Wire News Releases
Abiomed Announces Q3 FY 2021 Record Revenue of $232 Million, up 5% Year Over Year, With 31% Operating Margin
Abiomed announces Q3 fiscal year 2021 record revenue of $232 million, up 5% year over year with 31% operating margin. 
From Business Wire News Releases
Abiomed Third Quarter Fiscal 2021 Earnings and Conference Call Notification
Abiomed announces the company will release financial results for the third quarter of fiscal 2021 on January 28, 2021. 
From Business Wire News Releases
Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents
Abiomed (NASDAQ: ABMD) announces it has surpassed more than 1,000 patents worldwide, with more than 850 additional patents pending. Abiomed’s robust intellectual property portfolio protects its current... 
From Business Wire News Releases
Abiomed to Present at the 39th Annual J.P. Morgan Healthcare Conference
Abiomed to present at the 39th annual J.P. Morgan Healthcare conference. 
From Business Wire News Releases
First Patients, Including a COVID-19 Patient, Treated with Abiomed’s Innovative ECMO Technology
The first two patients in the world have been treated with the Abiomed Breethe OXY-1 System, including a COVID-19 patient in respiratory failure. 
From Business Wire News Releases
Two Milestones Achieved Toward Small Bore Access with Impella
Abiomed (NASDAQ: ABMD) announces the achievement of two milestones in the development of small bore access for the Impella heart pump. The Impella ECP heart pump has completed the first stage in its... 
From Business Wire News Releases
Abiomed to Hold Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Abiomed to hold fireside chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference. 
From Business Wire News Releases
Abiomed to Hold Fireside Chat at the Stephens Annual Investment Conference 2020
Abiomed to hold fireside chat at the Stephens Annual Investment Conference 2020. 
From Business Wire News Releases
First 1,000 Patients Treated with Impella 5.5 with SmartAssist, a Heart Pump Designed for Surgeons
Abiomed (NASDAQ: ABMD) announces 1,000 patients have been treated with the Impella 5.5 with SmartAssist heart pump in the first year after the U.S. Food and Drug Administration (FDA) granted Impella... 
From Business Wire News Releases
Axogen, Inc. Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
Abiomed Announces Q2 FY 2021 Revenue of $210 Million, Up 27% Over Q1 FY 2021 and Up 2% Over Q2 FY 2020 With 29.2% Operating Margin
Abiomed announces Q2 FY 2021 revenue of $210 million, up 27% over Q1 FY 2021 and up 2% over Q2 FY 2020 with 29.2% operating margin. 
From Business Wire News Releases
First Patients Treated with the World’s Smallest Heart Pump, the 9Fr Impella ECP
Abiomed (NASDAQ: ABMD) announces the first two patients have been treated with the Impella ECP expandable percutaneous heart pump. Impella ECP is the smallest heart pump in the world. It measures 9... 
From Business Wire News Releases
FDA Grants 510(k) Clearance for Abiomed’s Innovative Cardiopulmonary Support Technology
The U.S. FDA has granted Abiomed 510(k) clearance for an all-in-one, compact cardiopulmonary bypass system called the Abiomed Breethe OXY-1 System™. 
From Business Wire News Releases
Studies Presented at TCT Connect Associate Higher Survival With Early Identification of Right Heart Failure and Early Use of Impella RP
Data presented at TCT Connect, the 32nd annual scientific symposium of the Cardiovascular Research Foundation, finds early identification of right heart failure and early use of Impella RP is... 
From Business Wire News Releases
Data Presented at TCT Connect Finds Pre-PCI Use of Impella for AMI Cardiogenic Shock is Associated with Higher Survival, Particularly in Women
Two studies of AMI cardiogenic shock (AMICS) patients found higher survival when Impella was placed pre-PCI, compared to when Impella was placed after PCI. The findings were presented at TCT Connect,... 
From Business Wire News Releases
Abiomed to Host a Virtual Meeting to Discuss New Clinical Data Presented at TCT Connect
Abiomed to host a virtual meeting to discuss new clinical data presented at TCT Connect. 
From Business Wire News Releases
Largest Study of Hemodynamically Supported High-Risk PCI Patients Finds More Complete Revascularization with Impella Leads to Improved Outcomes
Abiomed (NASDAQ: ABMD) announces new PROTECT III study data that demonstrates reduced rates of MACCE (composite of death, stroke, myocardial infarction and repeat procedures) when Impella is used to... 
From Business Wire News Releases
Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves Left Ventricular Ejection Fraction
The Restore EF Study demonstrates the use of contemporary best practices, including attempting a more complete revascularization with Impella-supported high-risk PCI, is associated with significant... 
From Business Wire News Releases
Abiomed Second Quarter Fiscal 2021 Earnings and Conference Call Notification
Abiomed will release financial results for the second quarter of fiscal 2021 on Thursday, October 29, 2020 at 8:00 a.m. ET. 
From Business Wire News Releases
TCT Connect to Highlight How Impella Enables Improved Outcomes for High-Risk PCI, Cardiogenic Shock and Right Heart Failure Patients
The benefits of a more complete revascularization with Impella heart pumps in high-risk percutaneous coronary intervention (PCI) patients and the value of Impella protocol-based treatment for survival... 
From Business Wire News Releases
Axogen, Inc. Appoints Paul G. Thomas to Board of Directors
From GlobeNewswire News Releases
Abiomed to Hold Fireside Chat at the Raymond James North American Equities Conference
Abiomed to hold fireside chat at the Raymond James North American Equities Conference. 
From Business Wire News Releases
Abiomed to Hold Fireside Chat at the 18th Annual Morgan Stanley Global Healthcare Conference
Abiomed to hold fireside chat at the 18th annual Morgan Stanley Global Healthcare Conference. 
From Business Wire News Releases
Abiomed Announces Q1 FY 2021 Revenue of $165 Million and 21% Operating Margin
Abiomed announces Q1 FY 2021 revenue of $165 million and 21% operating margin. 
From Business Wire News Releases
FDA Issues Emergency Use Authorization for Impella Heart Pumps to Provide Unloading Therapy to COVID-19 Patients
The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular unloading and support to COVID-19... 
From Business Wire News Releases
Large Multi-Center Study in Japan Finds High Survival Rates with Use of Impella Heart Pump
A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart pump finds use of Impella is associated with a 77% survival rate at 30 days in AMI cardiogenic shock... 
From Business Wire News Releases
Abiomed First Quarter Fiscal 2021 Earnings and Conference Call Notification
Abiomed announced that on Thursday, August 6, 2020, the Company will release financial results for the first quarter of fiscal 2021. 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.